Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 81.67%
March 31, 2026 77.86%
December 31, 2025 77.80%
September 30, 2025 78.41%
June 30, 2025 78.33%
March 31, 2025 77.20%
December 31, 2024 72.86%
September 30, 2024 76.64%
June 30, 2024 76.43%
March 31, 2024 76.34%
December 31, 2023 83.74%
September 30, 2023 76.28%
June 30, 2023 75.00%
March 31, 2023 75.55%
December 31, 2022 83.54%
September 30, 2022 76.34%
June 30, 2022 75.47%
March 31, 2022 74.79%
December 31, 2021 84.62%
September 30, 2021 79.43%
June 30, 2021 77.26%
March 31, 2021 75.53%
December 31, 2020 73.25%
September 30, 2020 72.34%
Date Value
June 30, 2020 31.34%
March 31, 2020 40.12%
December 31, 2019 74.88%
September 30, 2019 85.82%
June 30, 2019 86.57%
March 31, 2019 89.24%
December 31, 2018 86.84%
September 30, 2018 86.31%
June 30, 2018 85.73%
March 31, 2018 85.58%
December 31, 2017 88.88%
September 30, 2017 85.85%
June 30, 2017 86.62%
March 31, 2017 85.57%
December 31, 2016 85.50%
September 30, 2016 86.86%
June 30, 2016 84.74%
March 31, 2016 86.48%
December 31, 2015 82.27%
September 30, 2015 82.54%
June 30, 2015 81.52%
March 31, 2015 80.95%
March 31, 2014 76.43%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 65.92%
Abbott Laboratories 52.64%
Alphatec Holdings, Inc. 62.90%
Artivion, Inc. 60.67%
Insulet Corp. 72.56%

Gross Profit Margin (Quarterly) Related Metrics